Journal of Global Infectious Diseases

CLINICAL EPIDEMIOLOGY
Year
: 2010  |  Volume : 2  |  Issue : 1  |  Page : 4--9

Helicobacter pylori and Hepatitis C virus coinfection in Egyptian patients


Samir El-Masry1, Mohamed El-Shahat1, Gamal Badra2, Mohamed F Aboel-Nour3, Mahmoud Lotfy4 
1 Department of Molecular Biology, Genetic Engineering and Biotechnology Research Institute, Minufiya University, Sadat City, Minufiya, Egypt
2 Department of Hepatology, National Liver Institute, Minufiya University, Minufiya, Egypt
3 Department of Zoology, Faculty of Science, Mansoura University, Mansoura, Egypt ; Department of Applied Medical Sciences, Jouf University, Qurayat, Saudi Arabia
4 Department of Molecular Biology, Genetic Engineering and Biotechnology Research Institute, Minufiya University, Sadat City, Minufiya, Egypt; Department of Applied Medical Sciences, Jouf University, Qurayat, Saudi Arabia

Correspondence Address:
Mohamed El-Shahat
Department of Molecular Biology, Genetic Engineering and Biotechnology Research Institute, Minufiya University, Sadat City, Minufiya, Egypt

Introduction: Chronic hepatitis C virus (HCV) infection is a leading cause of end-stage liver disease worldwide. It has been shown that Helicobacter pylori (H. pylori) plays an important role in chronic gastritis, peptic ulcer disease and gastric malignancies, and its eradication has been advocated. The association between H. pylori infection and liver cirrhosis in patients with hepatitis C virus has been documented in different parts of the world; nevertheless, no conclusive data is available in Egypt. Materials and Methods: In the present study, the status of H. pylori infection was sought in 90 patients with chronic HCV infection and in 66 HCV-free healthy controls. Results: The study showed that the H. pylori positivity was increased significantly (P = 0.03) in the HCV-infected patients when compared to that in healthy controls, where H. pylori infection was found in 50 (55.6%) out of 90 of the HCV-infected patients versus 26 (39.4%) out of 66 of the healthy controls. In HCV-infected patients, the prevalence of H. pylori infection was increased significantly (P = 0.04) from chronic active hepatitis to cirrhosis. H. pylori infection was present in 6/18 (33.3%), 10/21 (47.6%), 16/27 (59.3%), 18/24 (75.0%) patients with chronic active hepatitis, Child-Pugh score A, Child-Pugh score B and Child-Pugh score C, respectively. More importantly, the prevalence of H. pylori infection in HCV-infected patients was increased very significantly (P = 0.003) with increasing Meld (model for end-stage liver disease) score. The prevalence of H. pylori was documented in 9/28 (32.1%) patients with Meld score ≤10 and in 41/62 (66.1%) patients with Meld score >10. Conclusion: It may be stated that our results collectively reflect a remarkable increase in H. pylori prevalence with advancing hepatic lesions, and the eradication treatment may prove beneficial in those patients with chronic hepatitis C.


How to cite this article:
El-Masry S, El-Shahat M, Badra G, Aboel-Nour MF, Lotfy M. Helicobacter pylori and Hepatitis C virus coinfection in Egyptian patients.J Global Infect Dis 2010;2:4-9


How to cite this URL:
El-Masry S, El-Shahat M, Badra G, Aboel-Nour MF, Lotfy M. Helicobacter pylori and Hepatitis C virus coinfection in Egyptian patients. J Global Infect Dis [serial online] 2010 [cited 2019 Dec 13 ];2:4-9
Available from: http://www.jgid.org/article.asp?issn=0974-777X;year=2010;volume=2;issue=1;spage=4;epage=9;aulast=El-Masry;type=0